Evidence map›Paper›PMID 31215319›Full record

ArticleThe neuroradiology journal2019

Changes in metabolites in the brain of patients with fibromyalgia after treatment with an NMDA receptor antagonist.

Nicolas Fayed, Barbara Oliván, Yolanda Lopez Del Hoyo, Eva Andrés, Mari Cruz Perez-Yus, Alicia Fayed, Luisa F Angel, Antoni Serrano-Blanco, Miquel Roca, Javier Garcia Campayo

Open access · greenAbstract read
In one paragraph

Article in The neuroradiology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Effects ofPain reports · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Effect of Multiple Medicines on Dementia Initial Treatment: Experience and Thinking.American journal of Alzheimer's disease and other dementias
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Nicolas FayedDepartment of Radiology, Quirónsalud Hospital, Spain.
Barbara OlivánDepartment of Psychology and Sociology, University of Zaragoza, Spain.
Yolanda Lopez Del HoyoDepartment of Psychology and Sociology, University of Zaragoza, Spain.
Eva AndrésCIBER Epidemiology and Public Health, Clinical Epidemiology Unit, October 12 Hospital, Spain.
Mari Cruz Perez-YusPreventative Activities and Health Promotion Network (REDIAPP) (G06/170).
Alicia FayedDepartment of Neurorehabilitation, San Juan de Dios Hospital, Spain.
Luisa F AngelDepartment of Radiology, Quirónsalud Hospital, Spain.
Antoni Serrano-BlancoDepartment of Psychiatry, Parc Sanitari St. Joan of God and the St. Joan of God Foundation, Spain.
Miquel RocaHealth Sciences Research University Institute, Juan March Hospital, Illes Balears University, Spain.
Javier Garcia CampayoDepartment of Psychiatry, Miguel Servet Hospital and the University of Zaragoza. Aragon Institute for Health Research (IIS Aragon), Spain.ORCID https://orcid.org/0000-0002-3797-4218
Universidad de Zaragoza · ESHospital Quirónsalud Barcelona · ESRed de Investigación en Actividades Preventivas y Promoción de la Salud · ESCentro de Investigación Biomédica en Red · ESFundación Juan March · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aims of this work were to evaluate whether the treatment of patients with fibromyalgia with memantine is associated with significant changes in metabolite concentrations in the brain, and to explore any changes in clinical outcome measures. Magnetic resonance spectroscopy was performed of the right anterior and posterior insula, both hippocampi and the posterior cingulate cortex. Questionnaires on pain, anxiety, depression, global function, quality of life and cognitive impairment were used. Ten patients were studied at baseline and after three months of treatment with memantine. Significant increases were observed in the following areas: N-acetylaspartate (4.47 at baseline vs. 4.71 at three months,

Indexed as

AdultAnxietyAspartic AcidBrainCerebral CortexCholineCognitive DysfunctionCreatineDepressionExcitatory Amino Acid AntagonistsFemaleFibromyalgiaGlutamic AcidGlutamineGyrus CinguliHippocampusAspartic AcidCholineCreatineExcitatory Amino Acid AntagonistsGlutamic AcidGlutamineMemantineN-acetylaspartateReceptors, N-Methyl-D-AspartateFibromyalgiamagnetic resonance spectroscopymemantine

Identifiers

PMID31215319
PMCPMC6856999
OpenAlexW2951598154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.